Is Buying Manitex Capital Inc. Here a Winning Strategy?

 Is Buying Manitex Capital Inc. Here a Winning Strategy?

The stock of Manitex Capital Inc. (CVE:MNX) is a huge mover today! About 54,500 shares traded hands or 727.51% up from the average. Manitex Capital Inc. (CVE:MNX) has risen 6.00% since October 18, 2016 and is uptrending. It has outperformed by 1.38% the S&P500.
The move comes after 9 months positive chart setup for the $4.96M company. It was reported on Nov, 17 by Barchart.com. We have $0.99 PT which if reached, will make CVE:MNX worth $7.14 million more.

More news for Manitex Capital Inc. (CVE:MNX) were recently published by: Marketwatch.com, which released: “Manitex Capital Inc. acquires convertible debentures of Cold Water Fisheries …” on September 22, 2016. Marketwatch.com‘s article titled: “Manitex Capital Inc. announces that Valeo Pharma Inc. sold its dermatology …” and published on August 25, 2014 is yet another important article.

Manitex Capital Inc. is a Canada-based firm that specializes in acquiring interests in companies and participates in increasing shareholder value in these businesses. The company has a market cap of $4.96 million. The Firm operates through three divisions: diversified investments , biotechnology (biotech) and a pharmaceutical business (pharma). It currently has negative earnings. The investment segment holds interests in companies in the life science industry and also invests in marketable securities.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment